Effects of glucocorticoids on gene transcription

Adcock, 1999, Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement, Br. J. Pharmacol., 127, 1003, 10.1038/sj.bjp.0702613 Adcock, 2002, Molecular interactions between glucocorticoids and long-acting beta2-agonists, J. Allergy Clin. Immunol., 110, S261, 10.1067/mai.2002.129705 Allfrey, 1964, Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis, Proc. Natl. Acad. Sci. U. S. A., 51, 786, 10.1073/pnas.51.5.786 Ashburner, 2001, The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression, Mol. Cell. Biol., 21, 7065, 10.1128/MCB.21.20.7065-7077.2001 Baldwin, 2001, Series introduction: the transcription factor NF-kappaB and human disease, J. Clin. Invest., 107, 3, 10.1172/JCI11891 Barlev, 2001, Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases, Mol. Cell, 8, 1243, 10.1016/S1097-2765(01)00414-2 Barnes, 2002, Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids, Eur. Respir. J., 19, 182, 10.1183/09031936.02.00283202 Barnes, 1998, Transcription factors and asthma, Eur. Respir. J., 12, 221, 10.1183/09031936.98.12010221 Barnes, 1997, Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases, N. Engl. J. Med., 336, 1066, 10.1056/NEJM199704103361506 Barnes, 1998, Inflammatory mediators of asthma: an update, Pharmacol. Rev., 50, 515 Belikov, 2001, Hormone-induced nucleosome positioning in the MMTV promoter is reversible, EMBO J., 20, 2802, 10.1093/emboj/20.11.2802 Bledsoe, 2002, Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition, Cell, 110, 93, 10.1016/S0092-8674(02)00817-6 Boyes, 1998, Regulation of activity of the transcription factor GATA-1 by acetylation, Nature, 396, 594, 10.1038/25166 Braun, 2001, Transcription factor Sp3 is regulated by acetylation, Nucleic Acids Res., 29, 4994, 10.1093/nar/29.24.4994 Caelles, 1997, Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway, Genes Dev., 11, 3351, 10.1101/gad.11.24.3351 Chen, 1999, Pleiotropic signaling pathways in rapid, nongenomic action of glucocorticoid, Molec. Cell Biol. Res. Commun., 2, 145, 10.1006/mcbr.1999.0163 Chen, 2001, Duration of nuclear NF-kappaB action regulated by reversible acetylation, Science, 293, 1653, 10.1126/science.1062374 Croxtall, 2000, Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism, Br. J. Pharmacol., 130, 289, 10.1038/sj.bjp.0703272 Croxtall, 2002, Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells, Br. J. Pharmacol., 135, 511, 10.1038/sj.bjp.0704474 De Bosscher, 2000, Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell, Proc. Natl. Acad. Sci. U. S. A., 97, 3919, 10.1073/pnas.97.8.3919 Demoly, 1992, c-fos proto-oncogene expression in bronchial biopsies of asthmatics, Am. J. Respir. Cell Mol. Biol., 7, 128, 10.1165/ajrcmb/7.2.128 Demoly, 1995, Fos immunoreactivity assessment on human normal and pathological bronchial biopsies, Respir. Med., 89, 329, 10.1016/0954-6111(95)90003-9 De Ruijter, 2003, Histone deacetylases (HDACs): characterization of the classical HDAC family, Biochem. J., 370, 737, 10.1042/bj20021321 Donovan, 1999, NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation, J. Immunol., 163, 6827, 10.4049/jimmunol.163.12.6827 Eickelberg, 1999, Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells, J. Biol. Chem., 274, 1005, 10.1074/jbc.274.2.1005 Eickelberg, 1999, Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells, J. Biol. Chem., 274, 1005, 10.1074/jbc.274.2.1005 Evans, 2000, Partial purification and biochemical characterization of a membrane glucocorticoid receptor from an amphibian brain, J. Steroid Biochem. Mol. Biol., 72, 209, 10.1016/S0960-0760(00)00031-5 Fischle, 2001, The emerging role of class II histone deacetylases, Biochem. Cell. Biol., 79, 337, 10.1139/o01-116 Fletcher, 2000, Structure and dynamic properties of a glucocorticoid receptor-induced chromatin transition, Mol. Cell. Biol., 20, 6466, 10.1128/MCB.20.17.6466-6475.2000 Gu, 1997, Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain, Cell, 90, 595, 10.1016/S0092-8674(00)80521-8 Hart, 1998, Activation and localization of transcription factor, nuclear factor-kappaB, in asthma, Am. J. Respir. Crit. Care Med., 158, 1585, 10.1164/ajrccm.158.5.9706116 Hirasawa, 1998, Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells, J. Immunol., 161, 4939, 10.4049/jimmunol.161.9.4939 Huang, 2003, A role for cofactor–cofactor and cofactor–histone interactions in targeting p300, SWI/SNF and Mediator for transcription, EMBO J., 22, 2146, 10.1093/emboj/cdg219 Ito, 2000, Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12, Mol. Cell. Biol., 20, 6891, 10.1128/MCB.20.18.6891-6903.2000 Ito, 2002, A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression, Proc. Natl. Acad. Sci. U. S. A., 99, 8921, 10.1073/pnas.132556899 Janknecht, 1996, Versatile molecular glue. Transcriptional control, Curr. Biol., 6, 951, 10.1016/S0960-9822(02)00636-X Jenkins, 2001, Novel glucocorticoid receptor coactivator effector mechanisms, Trends Endocrinol. Metab., 12, 122, 10.1016/S1043-2760(00)00357-X Jenuwein, 2001, Translating the histone code, Science, 293, 1074, 10.1126/science.1063127 Jibiki, 2003, Apoptosis signal-regulating kinase 1-mediated signaling pathway regulates nitric oxide-induced activator protein-1 activation in human bronchial epithelial cells, Am. J. Respir. Crit. Care Med., 167, 856, 10.1164/rccm.2204042 Johnson, 2002, Effects of beta2-agonists on resident and infiltrating inflammatory cells, J. Allergy Clin. Immunol., 110, S282, 10.1067/mai.2002.129430 Kagoshima, 2001, Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation, Eur. J. Pharmacol., 429, 327, 10.1016/S0014-2999(01)01332-2 Karin, 1998, New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable?, Cell, 93, 487, 10.1016/S0092-8674(00)81177-0 Kassel, 2001, Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1, EMBO J., 20, 7108, 10.1093/emboj/20.24.7108 Kim, 2001, Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes, Nat. Med., 7, 437, 10.1038/86507 Lane, 1998, Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes, J. Clin. Invest., 102, 2156, 10.1172/JCI2680 Lasa, 2001, Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38, Mol. Cell. Biol., 21, 771, 10.1128/MCB.21.3.771-780.2001 Lasa, 2002, Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38, Mol. Cell. Biol., 22, 7802, 10.1128/MCB.22.22.7802-7811.2002 Li, 2003, Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification, Mol. Cell. Biol., 23, 3763, 10.1128/MCB.23.11.3763-3773.2003 Maneechotesuwan, 2002, The modulation of GATA-3 nuclear localization by fluticasone and salmeterol, Am. J. Respir. Crit. Care Med., 165, A616 Marzio, 2000, E2F family members are differentially regulated by reversible acetylation, J. Biol. Chem., 10887, 10.1074/jbc.275.15.10887 McNally, 2000, The glucocorticoid receptor: rapid exchange with regulatory sites in living cells, Science, 287, 1262, 10.1126/science.287.5456.1262 Mendes, 2003, Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids, Eur. Respir. J., 21, 989, 10.1183/09031936.03.00072402 Nair, 2001, Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA, Cancer Lett., 166, 55, 10.1016/S0304-3835(01)00418-9 Nasuhara, 1999, Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells. Evidence for additional regulatory steps in kappaB-dependent transcription, J. Biol. Chem., 274, 19965, 10.1074/jbc.274.28.19965 Nelson, 2003, Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers, J. Allergy Clin. Immunol., 112, 29, 10.1067/mai.2003.1558 Nissen, 2000, The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain, Genes Dev., 14, 2314, 10.1101/gad.827900 Norman, 2004, Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model, Nat. Rev., Drug Discov., 3, 27, 10.1038/nrd1283 Ohmori, 1997, Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB, J. Biol. Chem., 272, 14899, 10.1074/jbc.272.23.14899 Panettieri, 1990, Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression, Am. J. Physiol., 259, L365 Polesskaya, 2001, Interaction between acetylated MyoD and the bromodomain of CBP and/or p300, Mol. Cell. Biol., 21, 5312, 10.1128/MCB.21.16.5312-5320.2001 Powell, 1999, Immunoaffinity isolation of native membrane glucocorticoid receptor from S-49++ lymphoma cells: biochemical characterization and interaction with Hsp 70 and Hsp 90, Endocrine, 10, 271, 10.1007/BF02738626 Reichardt, 1998, DNA binding of the glucocorticoid receptor is not essential for survival, Cell, 93, 531, 10.1016/S0092-8674(00)81183-6 Reichardt, 2001, Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor, EMBO J., 20, 7168, 10.1093/emboj/20.24.7168 Rider, 1996, Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells, J. Immunol., 157, 2374, 10.4049/jimmunol.157.6.2374 Rogatsky, 1998, Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase, Proc. Natl. Acad. Sci. U. S. A., 95, 2050, 10.1073/pnas.95.5.2050 Rosenfeld, 2001, Coregulator codes of transcriptional regulation by nuclear receptors, J. Biol. Chem., 276, 36865, 10.1074/jbc.R100041200 Saccani, 2001, Two waves of nuclear factor kappaB recruitment to target promoters, J. Exp. Med., 193, 1351, 10.1084/jem.193.12.1351 Saccani, 2002, p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment, Nat. Immunol., 3, 69, 10.1038/ni748 Schacke, 2002, Mechanisms involved in the side effects of glucocorticoids, Pharmacol. Ther., 96, 23, 10.1016/S0163-7258(02)00297-8 Schacke, 2002, SEGRAs: a novel class of anti-inflammatory compounds, Ernst Schering Res. Found. Workshop, 357 Schacke, 2004, Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects, Proc. Natl. Acad. Sci. U. S. A., 101, 227, 10.1073/pnas.0300372101 Swantek, 1997, Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK, Mol. Cell. Biol., 17, 6274, 10.1128/MCB.17.11.6274 Tong, 2004, Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition, Biochem. Biophys. Res. Commun., 317, 463, 10.1016/j.bbrc.2004.03.066 Turlais, 2001, High-throughput screening for identification of small molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate), Anal. Biochem., 298, 62, 10.1006/abio.2001.5340 Urnov, 2001, Chromatin remodeling and transcriptional activation: the cast (in order of appearance), Oncogene, 20, 2991, 10.1038/sj.onc.1204323 Usmani, 2001, Glucocorticoid receptor immunolocalisation in sputum cells, Am. J. Respir. Crit. Care Med., 163, A230 Usmani, 2002, Glucocorticoid receptor activation following inhaled fluticasone and salmeterol, Am. J. Respir. Crit. Care Med., 165, A616 Viatour, 2003, Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3, J. Biol. Chem., 278, 46541, 10.1074/jbc.M306381200 Vries, 2001, A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300, EMBO J., 20, 6095, 10.1093/emboj/20.21.6095 Waterborg, 2000, Steady-state levels of histone acetylation in Saccharomyces cerevisiae, J. Biol. Chem., 275, 13007, 10.1074/jbc.275.17.13007 Yao, 2001, Regulation of transcription factor YY1 by acetylation and deacetylation, Mol. Cell. Biol., 21, 5979, 10.1128/MCB.21.17.5979-5991.2001 Zhong, 2002, The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1, Mol. Cell, 9, 625, 10.1016/S1097-2765(02)00477-X Zhu, 1996, Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation, J. Clin. Invest., 97, 421, 10.1172/JCI118431 Zlatanova, 2000, Linker histone binding and displacement: versatile mechanism for transcriptional regulation, FASEB J., 14, 1697, 10.1096/fj.99-0869rev